Inhibitors of the p38 cell signaling pathway as antiviral compounds against Junín virus

Arch Virol. 2022 Mar;167(3):935-940. doi: 10.1007/s00705-022-05388-9. Epub 2022 Feb 8.

Abstract

In the present study, we analyzed the modulation of p38 cell signaling by Junín virus (JUNV) and evaluated the antiviral activity of p38 inhibitors against JUNV. While JUNV induced a progressive activation of p38 throughout the infection in Vero cells, a partial downregulation of p38 phosphorylation was observed in HEK293 and HeLa cells. The compounds SB203580 and SB202190, which are selective inhibitors of p38, significantly reduced viral protein expression and viral yield in the cell lines examined, indicating that the p38 signaling pathway might be a promising antiviral target against JUNV infection.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Chlorocebus aethiops
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Junin virus* / physiology
  • Signal Transduction
  • Vero Cells
  • Virus Replication

Substances

  • Antiviral Agents